Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioLine RX Ltd (NASDAQ:BLRX)

1.11
Delayed Data
As of Mar 24
 +0.01 / +0.91%
Today’s Change
0.71
Today|||52-Week Range
1.42
+20.64%
Year-to-Date
No recent news for BioLine RX Ltd.

Today’s Trading

Previous close1.10
Today’s open1.10
Day’s range1.06 - 1.11
Volume406,070
Average volume (3 months)346,353
Market cap$65.7M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+16.35%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.28

Competitors

 Today’s
change
Today’s
% change
TCONTRACON Pharmaceutica...-0.20-4.65%
CEMIChembio Diagnostics ...+0.10+1.85%
PULMPulmatrix Inc-0.06-1.67%
IPCIIntellipharmaceutics...+0.05+2.21%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 23, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$0.00
Annual profit (last year)-$14.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Head-Investor Relations
Philip Adam Serlin
Chief Financial Officer
Mali Zeevi
Corporate headquarters
Modi'in, Tel Aviv

Forecasts


Search for Jobs